Functionalized silk spheres selectively and effectively deliver a cytotoxic drug to targeted cancer cells in vivo

Journal of Nanobiotechnology

Andrzej Mackiewicz¹  Hanna Dams-Kozlowska¹  Tomasz Deptuch¹  Anna Florczak¹  Karolina Penderecka¹  Andrzej Marszalek²  Anna Lewandowska²  Elzbieta Kramer² 

[1] Chair of Medical Biotechnology, Poznan University of Medical Sciences;Department of Tumor Pathology, Greater Poland Cancer Centre;

关键词: Silk;    Particles;    Functionalization;    Bioengineering;    Targeted drug delivery;    Cancer;   

DOI  :  10.1186/s12951-020-00734-y

来源: DOAJ

【 摘 要 】

Abstract Background Chemotherapy is often a first-line therapeutic approach for the treatment of a wide variety of cancers. Targeted drug delivery systems (DDSs) can potentially resolve the problem of chemotherapeutic drug off-targeting effects. Herein, we examined in vivo models to determine the efficacy of Her2-targeting silk spheres (H2.1MS1) as DDSs for delivering doxorubicin (Dox) to Her2-positive and Her2-negative primary and metastatic mouse breast cancers. Results The specific accumulation of H2.1MS1 spheres was demonstrated at the site of Her2-positive cancer. Dox delivered only by functionalized H2.1MS1 particles selectively inhibited Her2-positive cancer growth in primary and metastatic models. Moreover, the significant effect of the Dox dose and the frequency of treatment administration on the therapeutic efficacy was indicated. Although the control MS1 spheres accumulated in the lungs in Her2-positive metastatic breast cancer, the Dox-loaded MS1 particles did not treat cancer. Histopathological examination revealed no systemic toxicity after multiple administrations and at increased doses of Dox-loaded silk spheres. Although the studies were performed in immunocompetent mice, the H2.1MS1 silk spheres efficiently delivered the drug, which exerted a therapeutic effect. Conclusion Our results indicated that functionalized silk spheres that enable cell-specific recognition, cellular internalization, and drug release represent an efficient strategy for cancer treatment in vivo.

【 授权许可】

Unknown